vTv Therapeutics Inc (VTVT) — Cash Flow-to-Debt Ratio
vTv Therapeutics Inc (VTVT) has a Cash Flow-to-Debt Ratio of 1.03x as of March 2026, meaning its operating cash flow of $9.15 Million could theoretically repay 1% of its total liabilities ($8.85 Million) in one year. Explore how much of vTv Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
vTv Therapeutics Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for vTv Therapeutics Inc across 13 annual periods. Also explore VTVT total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for vTv Therapeutics Inc (2013–2025)
Year-by-year debt coverage analysis for vTv Therapeutics Inc. For market capitalisation and broader financial context, see vTv Therapeutics Inc (VTVT) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.99x | $-25.25 Million | $25.46 Million | ▲ +6.1% |
| 2024 | -1.06x | $-25.31 Million | $23.96 Million | ▼ -63.6% |
| 2023 | -0.65x | $-19.08 Million | $29.57 Million | ▼ -16.0% |
| 2022 | -0.56x | $-15.25 Million | $27.40 Million | ▲ +70.5% |
| 2021 | -1.88x | $-19.31 Million | $10.25 Million | ▼ -15.1% |
| 2020 | -1.64x | $-18.00 Million | $11.00 Million | ▼ -28.8% |
| 2019 | -1.27x | $-23.02 Million | $18.11 Million | ▼ -332.7% |
| 2018 | -0.29x | $-26.86 Million | $91.41 Million | ▼ -18.0% |
| 2017 | -0.25x | $-44.56 Million | $178.96 Million | ▲ +24.9% |
| 2016 | -0.33x | $-48.21 Million | $145.44 Million | ▼ -52.1% |
| 2015 | -0.22x | $-36.95 Million | $169.50 Million | ▼ -262.4% |
| 2014 | -0.06x | $-30.78 Million | $511.76 Million | ▲ +53.9% |
| 2013 | -0.13x | $-41.68 Million | $319.24 Million | — |